ATE219935T1 - Verwendung von ammoniumverbindungen und/oder harnstoff - Google Patents
Verwendung von ammoniumverbindungen und/oder harnstoffInfo
- Publication number
- ATE219935T1 ATE219935T1 AT97914690T AT97914690T ATE219935T1 AT E219935 T1 ATE219935 T1 AT E219935T1 AT 97914690 T AT97914690 T AT 97914690T AT 97914690 T AT97914690 T AT 97914690T AT E219935 T1 ATE219935 T1 AT E219935T1
- Authority
- AT
- Austria
- Prior art keywords
- infant
- urea
- sids
- pap
- disclosed
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract 6
- 239000004202 carbamide Substances 0.000 title abstract 6
- 150000003868 ammonium compounds Chemical class 0.000 title abstract 4
- 208000034972 Sudden Infant Death Diseases 0.000 abstract 6
- 206010042440 Sudden infant death syndrome Diseases 0.000 abstract 6
- 238000000034 method Methods 0.000 abstract 5
- 108010046334 Urease Proteins 0.000 abstract 3
- 235000013350 formula milk Nutrition 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- -1 ammonium ions Chemical class 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/62—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S297/00—Chairs and seats
- Y10S297/08—Inflatable bellows
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9601057A SE507696C2 (sv) | 1996-03-20 | 1996-03-20 | Användning av en fysiologisk ofarlig ammoniumförening och/ eller urea för profylax av plötslig spädbarnsdöd samt sätt att diagnostisera risk för plötslig spädbarnsdöd |
| PCT/SE1997/000361 WO1997034590A1 (en) | 1996-03-20 | 1997-03-04 | New use of ammonium compounds and/or urea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE219935T1 true ATE219935T1 (de) | 2002-07-15 |
Family
ID=20401857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97914690T ATE219935T1 (de) | 1996-03-20 | 1997-03-04 | Verwendung von ammoniumverbindungen und/oder harnstoff |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6333055B1 (de) |
| EP (1) | EP0888112B1 (de) |
| JP (1) | JP2000507936A (de) |
| AT (1) | ATE219935T1 (de) |
| AU (1) | AU722642B2 (de) |
| CA (1) | CA2249704A1 (de) |
| DE (1) | DE69713746T2 (de) |
| DK (1) | DK0888112T3 (de) |
| ES (1) | ES2176721T3 (de) |
| NO (1) | NO984194L (de) |
| NZ (1) | NZ331185A (de) |
| PT (1) | PT888112E (de) |
| SE (1) | SE507696C2 (de) |
| WO (1) | WO1997034590A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9572528B1 (en) | 2012-08-06 | 2017-02-21 | Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center | Monitor for SIDS research and prevention |
| EP3646739A1 (de) * | 2018-11-01 | 2020-05-06 | N.V. Nutricia | Ernährungszusammensetzung mit harnstoff und nichtverdaulichen oligosacchariden |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668772A (en) * | 1984-11-27 | 1987-05-26 | Nestec S.A. | Methods for controlling the viscosity of protein hydrolysates |
| CA1297721C (en) * | 1987-01-26 | 1992-03-24 | Shalan A. Al-Mashiki | PROCESS FOR LOWERING THE CONCENTRATION OF .beta.-LACTOGLOBULIN IN CHEESE WHEY |
| US5312839A (en) * | 1991-03-05 | 1994-05-17 | Regents Of The University Of California | Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
| US5169666A (en) * | 1991-11-14 | 1992-12-08 | The United States Of America As Represented By The Secretary Of Agriculture | Preparation of simulated human milk protein by low temperature microfiltration |
| AUPM864894A0 (en) | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
-
1996
- 1996-03-20 SE SE9601057A patent/SE507696C2/sv not_active IP Right Cessation
-
1997
- 1997-03-04 ES ES97914690T patent/ES2176721T3/es not_active Expired - Lifetime
- 1997-03-04 DE DE69713746T patent/DE69713746T2/de not_active Expired - Fee Related
- 1997-03-04 CA CA002249704A patent/CA2249704A1/en not_active Abandoned
- 1997-03-04 WO PCT/SE1997/000361 patent/WO1997034590A1/en not_active Ceased
- 1997-03-04 US US09/142,145 patent/US6333055B1/en not_active Expired - Fee Related
- 1997-03-04 EP EP97914690A patent/EP0888112B1/de not_active Expired - Lifetime
- 1997-03-04 AU AU21840/97A patent/AU722642B2/en not_active Ceased
- 1997-03-04 AT AT97914690T patent/ATE219935T1/de not_active IP Right Cessation
- 1997-03-04 NZ NZ331185A patent/NZ331185A/xx unknown
- 1997-03-04 JP JP9533393A patent/JP2000507936A/ja active Pending
- 1997-03-04 PT PT97914690T patent/PT888112E/pt unknown
- 1997-03-04 DK DK97914690T patent/DK0888112T3/da active
-
1998
- 1998-09-11 NO NO984194A patent/NO984194L/no not_active Application Discontinuation
-
2001
- 2001-11-15 US US09/987,558 patent/US20030021856A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SE507696C2 (sv) | 1998-07-06 |
| DE69713746D1 (de) | 2002-08-08 |
| NO984194D0 (no) | 1998-09-11 |
| AU2184097A (en) | 1997-10-10 |
| SE9601057L (sv) | 1997-09-21 |
| JP2000507936A (ja) | 2000-06-27 |
| EP0888112B1 (de) | 2002-07-03 |
| EP0888112A1 (de) | 1999-01-07 |
| US6333055B1 (en) | 2001-12-25 |
| DE69713746T2 (de) | 2002-11-21 |
| ES2176721T3 (es) | 2002-12-01 |
| NZ331185A (en) | 2000-05-26 |
| SE9601057D0 (sv) | 1996-03-20 |
| PT888112E (pt) | 2002-11-29 |
| US20030021856A1 (en) | 2003-01-30 |
| AU722642B2 (en) | 2000-08-10 |
| NO984194L (no) | 1998-09-11 |
| DK0888112T3 (da) | 2002-10-21 |
| CA2249704A1 (en) | 1997-09-25 |
| WO1997034590A1 (en) | 1997-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014415D0 (no) | Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens | |
| TR200901979T2 (tr) | Antikolinerjik etkili bileşik ve ?-mimetikler bazında yeni ilaç bileşimleri. | |
| ES2071725T3 (es) | Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard. | |
| BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
| LU90192I2 (fr) | Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc) | |
| MX9706380A (es) | Guanidinas de acidos alquenil-carboxilicos sustituidos con fenilo, procedimientos para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como un medicamento que las contiene. | |
| ATE16191T1 (de) | Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten. | |
| GR3002672T3 (en) | Compositions and methods for the treatment of bleeding disorders | |
| DE69030616D1 (de) | Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion | |
| BR9713921A (pt) | Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa | |
| AU6698894A (en) | 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
| Crawhall et al. | Further observations on use of D-penicillamine in cystinuria | |
| SE8500996D0 (sv) | Method of treatment | |
| ATE219935T1 (de) | Verwendung von ammoniumverbindungen und/oder harnstoff | |
| DE69713588D1 (de) | Diagnostische zusammensetzung | |
| ES8700054A1 (es) | Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico. | |
| Edgar et al. | Dietary cysteic acid serves as a precursor of taurine for cats | |
| ES8504109A1 (es) | Procedimiento de producir compuestos para el tratamiento de la hipertension | |
| ATE110568T1 (de) | Pharmazeutisches präparat zur behandlung des katarakts. | |
| ATE140922T1 (de) | 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| ATE324892T1 (de) | Antimutagenmittel | |
| KR890001555A (ko) | 요산 배설용 조성물 | |
| Hussein | Juvenile Dermatomyositis with Respiratory Failure and Peripheral Nerve Paralyses-A Case Report |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |